Zahirabad, India

Ningam Srinivasreddy

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Reddy's Laboratories Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ningam Srinivasreddy. Retrieved from https://idiyas.com/inventor/ningam-srinivasreddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Ningam Srinivasreddy

Introduction

Ningam Srinivasreddy is a notable inventor based in Zahirabad, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on moxifloxacin hydrochloride.

Latest Patents

Ningam holds a patent for the "Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof." This patent describes a new crystalline form of moxifloxacin monohydrochloride, along with processes for its preparation. It also includes compositions, pharmaceutical compositions, and methods that utilize this crystalline form.

Career Highlights

Ningam Srinivasreddy is associated with Reddy's Laboratories Ltd., a prominent player in the pharmaceutical industry. His work has contributed to advancements in drug formulation and delivery.

Collaborations

He has collaborated with notable coworkers, including Manne Satyanarayana Reddy and Sajja Eswaraiah, to further enhance the research and development efforts at Reddy's Laboratories.

Conclusion

Ningam Srinivasreddy's innovative contributions to pharmaceutical sciences, particularly through his patent on moxifloxacin hydrochloride, highlight his role as a significant inventor in the industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…